Navigation Links
New Diarrhoea Bug Warning in Australia

Australia must prepare for the possible outbreak of a highly infectious strain of a diarrhoea-causing organism, scientists have warned in the latest issue// of the Medical Journal of Australia (MJA).

Clostridium difficile (C. difficile) is the most commonly diagnosed cause of infectious hospital-acquired diarrhoea in developed countries, including Australia.

Canada, Europe, and the US have all recently seen sudden increases in rates of C. difficile infection and high mortality rates, with people over 65 years of age being most at risk, suggesting the emergence of a highly virulent strain of C. difficile.

Professor Thomas Riley, Professor in Microbiology and Immunology at the University of Western Australia, outlines the characteristics of the various strains of C. difficile.

"Acquisition of C. difficile is facilitated by its ability to form spores that are resistant to many disinfectants, so that it remains viable in the hospital environment for long periods of time," says Prof Riley.

He adds that C. difficile strains have also shown resistance to one group of antibiotics (fluoroquinolones), possibly through overuse of these medications.

The virulent strain cannot be differentiated from other strains without molecular typing, which makes it difficult to know whether the organism has reached Australia's shores.

He says many laboratories in Australia, to save money and time, are using a testing technology that may not detect the virulent C. difficile strain.

Prof Riley recommends targeted surveillance, with one or two laboratories being funded periodically to test samples from a number of different hospitals.

"The value of sensible policies regarding antibiotic use, and good infection control staff and procedures, cannot be over emphasised," he says.

"In the long term, such initiatives are likely to have an impact not only on C. difficile-associated diarrhoea but also on other infection control problem organisms."


'"/>




Related medicine news :

1. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
2. Deadly Diarrhoea Vaccine – Trail Results Promising
3. Health Department Geared Up To Meet Diarrhoea Cases
4. Child Diarrhoea Due To Rotavirus:Quick Relief By Short Course Drug
5. Students of Dharamsala Hospitalized for Diarrhoea
6. Early Warning System For Breast Cancer
7. Warning on radiowave exposure
8. A Seizure Late In Life Could be A Stroke Warning
9. Blood Pressure An Early Warning Sign Of Alzheimer’s Disease
10. Early Warning Signs Of Heart Disease
11. Warning Issued by FDA on consumption of the drug Tysabri used to treat Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: